← Research library

Possibilities of the pharmacological correction of adaptive reactions of human organism in short-term moving from middle to high altitude]

Comparison in people · 2014

What was studied
Volunteers moving from 1,670 m to 3,750 m after 15 days at middle altitude
Main finding
An altitude-adaptation comparison reported earlier metabolic adaptation with combined Metaprot and Ladasten than with Hypoxen or placebo. The abstract does not quantify the work-capacity improvement.

Adaptation timing · Combination: within first hours; Hypoxen: by day 3; placebo: still developing on day 3 · Authors’ descriptive metabolic time course, not a timed endurance effect

Reported findings and study design

An altitude-adaptation comparison reported earlier metabolic adaptation with combined Metaprot and Ladasten than with Hypoxen or placebo. The abstract does not quantify the work-capacity improvement.

Volunteers acclimatized for 15 days at 1,670 m before moving to 3,750 m; group sizes not supplied.

Population or model Volunteers moving from 1,670 m to 3,750 m after 15 days at middle altitude

Results · Primary-publication indexed abstract; no full-text table appraisal
MeasureResultComparison, timing and statistics
Adaptation timingCombination: within first hours; Hypoxen: by day 3; placebo: still developing on day 3Authors’ descriptive metabolic time course, not a timed endurance effect
Exercise tolerance and blood-cell measuresReported stronger responses with the combinationNo absolute work or blood-cell effect sizes supplied
Studied armsMetaprot 0.125 g + Ladasten 0.1 g; Hypoxen 0.5 g; placeboCombination effect cannot be assigned to either component alone

No component-only arms are described in the abstract. Earlier metabolic adaptation does not establish safe high-altitude use or independent bromantane efficacy.

Source for these results ↗ · Reviewed 2026-11-01

Study limitations and source details

Study limitations

  • No single-component arms are described, so the study cannot isolate contributions or establish synergy.
  • Enrollment and allocation details require full-text review.
  • Not a validated altitude-illness prevention strategy.

Source details

Indexed citation and abstract checked through Europe PMC / PubMed. Original methods and risk of bias not fully appraised.

Sources checked

Citation

Human comparative studyEnglish abstract

Kundashev UK, Zurdinov AZ, Barchukov VG. Possibilities of the pharmacological correction of adaptive reactions of human organism in short-term moving from middle to high altitude] Eksperimental'naia i klinicheskaia farmakologiia 77(9):32-37. PMID 25365868

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards